ARTICLE | Company News
Biovail files Cardizem XL NDA
August 27, 2001 7:00 AM UTC
Biovail (BVF; TSE:BVF) submitted an NDA to the FDA for Cardizem XL diltiazem, a calcium channel blocker to treat hypertension and angina. Cardizem XL is a once-daily formulation of Cardizem from Avent...